Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT00281827
Status:
TERMINATED
Last Update Posted:
2017-12-28
First Post:
2006-01-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2002LS013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None